Oregon 2025 Regular Session

Oregon House Bill HB2506

Introduced
1/13/25  
Refer
1/17/25  
Refer
5/6/25  

Caption

Relating to substance use disorder treatment; declaring an emergency.

Impact

One significant aspect of HB2506 is the repeal of the prohibition against operating methadone clinics within 1,000 feet of schools or licensed child care facilities. This change is designed to enhance accessibility to opioid treatments and improve the immediate care options available to individuals seeking help for substance use disorders. The bill mandates the development of a funding model to further incentivize community-based services, aiming for better integration of health care providers in the continuum of care for those affected by substance use disorders.

Summary

House Bill 2506 is a legislative measure focused on improving access to treatment for individuals with substance use disorders, particularly concerning opioid use. The bill directs the Alcohol and Drug Policy Commission and the Oregon Health Authority to establish state-wide policies that support the availability of medications for opioid use disorder within physical health care settings. A major highlight of this bill is the emphasis on transitioning patients from emergency services to community-based care, establishing a network of low-barrier community substance use disorder clinics and ensuring that outpatient providers can accept referrals from emergency departments.

Sentiment

The response to HB2506 has generally been positive among legislators and health advocates who focus on addiction and recovery. Proponents argue that the measures introduced in this bill will significantly decrease barriers to accessing necessary treatments and reflect a proactive approach in addressing the opioid crisis. However, there are voices of contention regarding the implications of expanding access to treatment providers, particularly methadone clinics, raising concerns that this could impact community safety or perceptions of substance use services in proximity to schools.

Contention

Debate surrounding HB2506 centers on balancing the need for accessible treatment options with community concerns about substance use and recovery services' location. While supporters advocate for the improved health outcomes resulting from increased accessibility, opponents worry about potential negative impacts on community dynamics and the prevalence of treatment facilities near child-focused areas. The bill's deadline requiring a progress report by September 2026 illustrates the legislative commitment to monitoring outcomes and adjusting policies based on real-world effectiveness.

Companion Bills

No companion bills found.

Similar Bills

US HB830

SAFE Act Save Americans from the Fentanyl Emergency Act

MA H2227

Replacing archaic and stigmatizing language for substance use

MI HB4948

Controlled substances: other; sentencing guidelines for retail sale of products containing ephedrine or pseudoephedrine; modify. Amends sec. 13m, ch. XVII of 1927 PA 175 (MCL 777.13m). TIE BAR WITH: HB 4947'25

MI HB4167

Criminal procedure: sentencing guidelines; sentencing guidelines for illicit use of xylazine; provide for. Amends sec. 13m, ch. XVII of 1927 PA 175 (MCL 777.13m).

NJ S829

"CJ's Law"; Criminalizes manufacture, sale, and possession of substances containing kratom.

NJ A1617

"CJ's Law"; Criminalizes manufacture, sale, and possession of substances containing kratom.

MI HB4256

Criminal procedure: sentencing guidelines; sentencing guidelines for delivering, manufacturing, or possessing with intent to deliver certain controlled substances; amend. Amends sec. 13m, ch. XVII of 1927 PA 175 (MCL 777.13m). TIE BAR WITH: HB 4255'25

MI SB0431

Criminal procedure: sentencing guidelines; sentencing guidelines for delivering, manufacturing, or possessing with intent to deliver heroin or fentanyl; amend. Amends sec. 13m, ch. XVII of 1927 PA 175 (MCL 777.13m). TIE BAR WITH: SB 0430'25